Physician profile
Sean B Orenstein
NPI 1053518944
$480,374.96
in general payments reported to CMS, 2019-2025
14 companies · $98K in 2025
The $98K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165K · 2020: $54K · 2021: $14K · 2022: $45K · 2023: $5,280 · 2024: $99K · 2025: $98K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $87K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $65K · Consulting Fee: $24K · Travel and Lodging: $19K · Food and Beverage: $7,553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $86,525.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $65,120.00 |
| Consulting Fee | $24,100.00 |
| Travel and Lodging | $19,130.61 |
| Food and Beverage | $7,552.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $286,107.96 | 2019-2025 | Arista, Phasix Mesh, Arista Ah Flexitip |
| Medtronic, INC. | $80,344.03 | 2021-2025 | Progrip, Absorbatack, Versatex |
| Allergan, INC. | $46,295.75 | 2019-2022 | |
| Intuitive Surgical, INC. | $30,343.39 | 2019-2022 | |
| Tela Bio, INC. | $27,911.46 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Covidien Lp | $5,816.00 | 2019-2020 | |
| Abbvie INC. | $1,012.50 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $918.19 | 2019 | |
| Integra Lifesciences Corporation | $731.20 | 2021-2022 | |
| Conmed Corporation | $392.12 | 2022-2025 | Airseal, System 2450, Visiclear |
| W. L. Gore & Associates, INC. | $196.20 | 2021-2022 | |
| Becton, Dickinson and Company | $174.79 | 2023 | Phasix Mesh |
| Cook Biotech Incorporated | $81.66 | 2023 | |
| Ethicon US, LLC | $49.71 | 2025 | Echelon; Endopath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Orenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.